Continuing Education

The Evolving Treatment Paradigm of HIV Therapy: Addressing Antiretroviral Tolerability and Barriers to Adherence

October 15th 2021

This CE article will explore barriers to uptake and adherence of ART as well as inform about the complexities of HIV management in specific patient populations.

Melatonin Supplementation in Circadian Rhythm Disorders and Sleep Regulation: The Role of the Retail Pharmacist

September 15th 2021

This activity will review the regulation of sleep and provide practical counseling points for patients about the safe and proper use of melatonin supplements.

Influenza Vaccination: Opportunities for Pharmacists as Patient Advocates, Educators, and Administrators

September 14th 2021

This activity provides pharmacists with insights into the status of influenza vaccination rates, as well as actionable strategies to improve vaccination outcomes among patients in future influenza seasons.

New and Emerging Trends in CLL Drug Therapy and the Pharmacist's Role in Patient Care

September 10th 2021

This program will equip pharmacists to navigate the changing landscape and their role in coordination of care and optimization of patient outcomes.

Myasthenia Gravis: Treatment Considerations for Specialty Pharmacists

September 8th 2021

This activity will provide a review and update of MG treatment options and include video clips highlighting key counseling pearls for specialty pharmacists.

The Expanding Treatment Landscape of Inflammatory Bowel Disease: The Role of the Specialty Pharmacist

September 3rd 2021

The activity will explore specialty pharmacy operational and clinical practices that have the greatest potential to improve outcomes for patients with IBD.

Augmenting Awareness and Preventing Herpes Zoster: The Multiple Roles of the Pharmacist

September 3rd 2021

This webinar will explore the pharmacist’s key role in educating patients about the disease burden and complications of HZ, and safety and efficacy information on available vaccines to overcome barriers to vaccination.

HR+/HER2- Advanced Breast Cancer Treatment With CDK4/6 Inhibitors: Improving Care for Patients

February 21st 2021

This activity will identify appropriate use of endocrine and CKD4/6 inhibitor therapies in patients with HR+/HER2- breast cancer.

Reaching Out: The Benefit of Treating Influenza: The Role of the Pharmacist as Patient Educator and Advocate

August 20th 2021

Reaching Out: The Importance of Promptly Treating Influenza and the Role of the Pharmacist

August 20th 2021